Stefania De Trane
Dirigente medico

Richiedi appuntamento
Specializzazione
  • Fisiatria
Istituto
Contatti
  • 080.7814111
  • [javascript protected email address]
  • An Observational Cross-Sectional Study of Gender and Disability as Determinants of Person-Centered Medicine in Botulinum Neurotoxin Treatment of Upper Motoneuron Syndrome
    Authors: Del Prete CM, Viva MG, De Trane S, Brindisino F, Barassi G, Specchia A, Di Iorio A, Pellegrino R.. Toxins (Basel). 2022 Mar 30;14(4):246. doi: 10.3390/toxins14040246. PMID: 35448855; PMCID: PMC9024520.
     
  • Cervical Spine Manipulations: Role of Diagnostic Procedures, Effectiveness, and Safety from a Rehabilitation and Forensic Medicine Perspective: A Systematic Review
    Authors: Bernetti A, La Russa R, de Sire A, Agostini F, De Simone S, Farì G, Lacasella GV, Santilli G, De Trane S, Karaboue M, Ruiu P, Mangone M, Leigheb M, Santilli V, Fiore P.. Diagnostics (Basel). 2022 Apr 23;12(5):1056. doi: 10.3390/diagnostics12051056. PMID: 35626212; PMCID: PMC9139983.
     
  • Therapeutic Exercise and Conservative Injection Treatment for Early Knee Osteoarthritis in Athletes: A Scoping Review
    Authors: Tognolo L, Maccarone MC, De Trane S, Scanu A, Masiero S, Fiore P. Medicina (Kaunas). 2022 Jan 3;58(1):69. doi: 10.3390/medicina58010069. PMID: 35056377; PMCID: PMC8778069.
     
  • Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
    Authors: Allen-Philbey K, De Trane S, Mao Z, Álvarez-González C, Mathews J, MacDougall A, Stennett A, Zhou X, Yildiz O, Adams A, Bianchi L, Blain C, Chapman C, Chung K, Constantinescu CS, Dalton C, Farrell RA, Fisniku L, Ford H, Gran B, Hobart J, Khaleeli Z, Mattoscio M, Pavitt S, Pearson O, Peruzzotti-Jametti L, Scalfari A, Sharrack B, Silber E, Tallantyre EC, Webb S, Turner BP, Marta M, Gnanapavan S, Juliusson G, Giovannoni G, Baker D, Schmierer K. Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Ther Adv Neurol Disord. 2021 Nov 25;14:17562864211057661. doi: 10.1177/17562864211057661. PMID: 35173808; PMCID: PMC8842147.
     
  • Intensive Neurofeedback-based Training to Improve Impaired Attention and Executive Functions Secondary to Resection of Tuberculum Sellae Meningioma: A Case Study
    Authors: Gianvito Lagravinese, MsC, Rodolfo Sardone, MPh, Stefania De Trane, MD, Fabiana Montenegro, BSc, Ernesto Losavio, MD, Pietro Fiore, MD, Petronilla Battista, PhD. Neuroregulation. 2021.09.30
    DOI: https://doi.org/10.15540/nr.8.3.149.
     
  • Evidence for a Window of Enhanced Plasticity in the Human Motor Cortex Following Ischemic Stroke
    Authors: Brenton Hordacre, Duncan Austin, Katlyn E Brown, Lynton Graetz, Isabel Pareés, Stefania De Trane, Ann-Maree Vallence, Simon Koblar, Timothy Kleinig, Michelle N McDonnell, Richard Greenwood, Michael C Ridding, John C Rothwell
    Neurorehabil Neural Repair. 2021 Apr;35(4):307-320. doi: 10.1177/1545968321992330. Epub 2021 Feb 12.
     
  • Severe skin reactions associated with cladribine in people with multiple sclerosis
    Authors: Mateo-Casas M, Reyes S, O'Toole EA, De Trane S, Yildiz O, Allen-Philbey K, Mathews J, Baker D, Giovannoni G, Schmierer K.
    Mult Scler Relat Disord. 2020 Aug;43:102140. doi: 10.1016/j.msard.2020.102140. Epub 2020 Apr 28. PMID: 32454296
     
  • Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?
    Authors: Mateo-Casas M, Reyes S, De Trane S, Edwards F, Espasandin M, Anjorin G, Baker D, Schmierer K, Giovannoni G.
    eNeurologicalSci. 2020 Oct 9;21:100279. doi: 10.1016/j.ensci.2020.100279. eCollection 2020 Dec. PMID: 33163633
     
  • Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.
    Authors: Mao Z, Álvarez-González C, Allen-Philbey K, De Trane S, Yildiz O, Campion T, Adams A, Turner BP, Marta M, Gnanapavan S, Espasandin M, Mathews J, Giovannoni G, Baker D, Schmierer K.
    Mult Scler Relat Disord. 2019 Jan;27:247-253. doi: 10.1016/j.msard.2018.11.001. Epub 2018 Nov 2. PMID: 30419510
     
  • Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
    Authors: Mao Z, Álvarez-Gonzalez C, De Trane S, Yildiz O, Albor C, Doctor G, Soon D, Pepper G, Turner BP, Marta M, Mathews J, Giovannoni G, Baker D, Schmierer K.
    Mult Scler J Exp Transl Clin. 2018 Jun 26;4(2):2055217318783767. doi: 10.1177/2055217318783767. eCollection 2018 Apr-Jun. PMID: 30090639

Presta servizio in queste sedi

Mappa del sito
Per i pazienti e le loro famiglie
Aree specialistiche
Trova la cura
Prenotazioni
I professionisti
News
Per i medici
La gestione del paziente cronico
Formazione
Informazioni per gli ospedali
Per i ricercatori
Organizzazione della ricerca
I progetti
Partnership
Comitato etico
Dove siamo
Chi siamo
Amministrazione trasparente
Bandi e avvisi
Lavora con noi
X

Stiamo svolgendo una ricerca per migliorare il nostro sito web.

Le chiediamo qualche minuto del suo tempo per rispondere ad alcune domande utili a creare un sistema digitale a misura di persona

La ringraziamo per il tempo dedicato.

Accedi al questionario
GH4T12Fv7resHnpU